Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

Go back to Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
(NASDAQ: JAGX) Delayed: 0.41 -0.19 (31.67%)
Previous Close $0.60    52 Week High $4.60 
Open $0.51    52 Week Low $0.81 
Day High $0.51    P/E N/A 
Day Low $0.40    EPS $0.00 
Volume 971,888